Inveready
Overview
Inveready is a leading Spanish alternative investment and wealth management firm that provides financing solutions to companies throughout their life-cycle through venture capital, growth capital, venture debt, private equity, infrastructure, and strategic public equity investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Telum Therapeutics | Jul 2026 | Series A | Co-investor |
| Dolfin | May 2026 | Seed | Co-investor |
| Fresh People | May 2026 | Seed | Lead |
| 53Biologics | Mar 2026 | Strategic | Co-investor |
| Wikifarmer | Mar 2026 | VC Round | Co-investor |
Key People
Ignacio Fonts
Non Executive President, Managing Partner & CEO, CEO, Member BOD
Beltrán Mora-Figueroa
Managing Partner
Aniol Brosa
General Partner
Borja Fernández Espejel
General Partner At Inveready - Head Of Club Deal
Raul Gallego
General Partner
Eduard Feliu Torné
CFO Partner
Antonio H.
Director - Life Sciences
Ignacio Puig Masllorens
Partner Venture Debt Investment Director
Óscar Gómez García
Investor
Samuel Sánchez González
Investor
Gonzalo Simón Palmeiro
Venture Capital Off-Cycle Intern
Laia Prats Ibáñez
Venture Capital And Corporate Lawyer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
